Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-10-11
2010-12-07
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S365000, C514S378000, C514S422000, C548S131000, C548S204000, C548S247000, C548S518000, C548S527000
Reexamination Certificate
active
07846950
ABSTRACT:
The present invention provides novel compounds with histamine-H3 receptor antagonist or inverse agonist activity. In particular, the invention provides a compound of Formula I, or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the compounds, methods of treatment employing these compounds and compositions, and intermediates and methods for making these compounds. The invention provides methods of using compounds and pharmaceutical compositions to treat obesity, cognitive deficiences, narcolepsy, and other histamine H3 receptor-related diseases.
REFERENCES:
patent: 2009/0118254 (2009-05-01), Beavers et al.
patent: WO 02/076925 (2002-10-01), None
patent: WO 2005/121080 (2005-12-01), None
Jesudason Cynthia Darshini
Stevens Freddie Craig
Eli Lilly and Company
Saeed Kamal A
Wood Dan L.
LandOfFree
Histamine H3 receptor inhibitors, preparation and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Histamine H3 receptor inhibitors, preparation and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Histamine H3 receptor inhibitors, preparation and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4173037